Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page underwent a visual/UI refresh with a new header and updated formatting; no core content such as study title, NCT number, eligibility criteria, or outcomes changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status guidance, plus a pointer to cc.nih.gov; - Bumped version from v3.1.0 to v3.2.0.
    Difference
    6%
    Check dated 2025-10-05T13:22:41.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Rebranding: replace Genetic and Rare Diseases Information Center with MedlinePlus Genetics and update to Revision v3.1.0; related topics added. Old center name and resources removed (v3.0.2).
    Difference
    1%
    Check dated 2025-09-28T09:28:27.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic on Ovarian cancer from the page.
    Difference
    0.4%
    Check dated 2025-09-21T06:32:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. No substantive changes to core content, pricing, or time-sensitive information.
    Difference
    0.3%
    Check dated 2025-09-14T00:09:57.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T21:10:12.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.